samedan logo

home > pmps > winter 2004 > taking the transdermal route: technological advances point to a new star in drug delivery


Dear guest!

article: Taking the Transdermal Route: Technological Advances Point to a New Star in Drug Delivery
format: Adobe Acrobat PDF file
cost: £


News and Press Releases

Gilead and Kite Oncology Demonstrate Transformative Impact of Cell Therapy and Promise of Blood Cancer Portfolio at ASH 2022

Stockley Park, UK 3 November 2022 Gilead Sciences, Inc. and Kite, a Gilead Company, will support 30 data presentations, including seven oral presentations in large B-cell lymphoma (LBCL) and two oral presentations on investigator-sponsored studies in acute myeloid leukaemia (AML), during the 64th Annual American Society of Hematology (ASH) Annual Meeting (10-13 December).
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement